-
1Academic Journal
المؤلفون: Holmsten, K, Omland, LH, Als, AB, Agerbaek, M, Dohn, LH, Lindberg, H, Jensen, NV, Carus, A, Moe, M, Hosseini, A, Radkiewicz, C, Pappot, H, Ullen, A
المصدر: Bladder cancer (Amsterdam, Netherlands). 8(1):71-80
مصطلحات موضوعية: Medicin och hälsovetenskap
-
2Academic Journal
المؤلفون: Holmsten, K, Jensen, NV, Mouritsen, LS, Jonsson, E, Mellnert, C, Agerbaek, M, Nilsson, C, Moe, M, Carus, A, Ofverholm, E, Lahdenpera, O, Brandberg, Y, Johansson, H, Hellstrom, M, von der Maase, H, Pappot, H, Ullen, A
المصدر: European journal of cancer (Oxford, England : 1990). 127:173-182
مصطلحات موضوعية: Medicin och hälsovetenskap
-
3Academic Journal
المؤلفون: Holmsten, K, Dohn, LH, Jensen, NV, Shah, CH, Jaderling, F, Pappot, H, Ullen, A
المصدر: Oncology letters. 12(2):1293-1300
مصطلحات موضوعية: Medicin och hälsovetenskap
-
4Academic Journal
المؤلفون: McDermott, DF, Lee, J-L, Bjarnason, GA, Larkin, JMG, Gafanov, RA, Kochenderfer, MD, Jensen, NV, Donskov, F, Malik, J, Poprach, A, Tykodi, SS, Alonso-Gordoa, T, Cho, DC, Geertsen, PF, Climent Duran, MA, DiSimone, C, Silverman, RK, Perini, RF, Schloss, C, Atkins, MB
المساهمون: Larkin, James
مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Carcinoma, Renal Cell, Female, Follow-Up Studies, Humans, Kidney Neoplasms, Male, Middle Aged, Non-Randomized Controlled Trials as Topic, Prognosis, Survival Rate
جغرافية الموضوع: United States
وصف الملف: Print-Electronic; 1028; application/pdf
Relation: Journal of Clinical Oncology, 2021, 39 (9), pp. 1020 - 1028; https://repository.icr.ac.uk/handle/internal/5338
-
5Academic Journal
المؤلفون: Holmsten, K, Dohn, L, Jensen, NV, Shah, CH, Jaderling, F, Pappot, H, Ullen, A
المصدر: Oncology letters. 13(6):5035-5035
مصطلحات موضوعية: Medicin och hälsovetenskap
-
6Academic Journal
المؤلفون: Petrylak, DP, de Wit, R, Chi, KN, Drakaki, A, Sternberg, CN, Nishiyama, H, Castellano, D, Hussain, S, Fléchon, A, Bamias, A, Yu, EY, van der Heijden, MS, Matsubara, N, Alekseev, B, Necchi, A, Géczi, L, Ou, Y-C, Coskun, HS, Su, W-P, Hegemann, M, Percent, IJ, Lee, J-L, Tucci, M, Semenov, A, Laestadius, F, Peer, A, Tortora, G, Safina, S, del Muro, XG, Rodriguez-Vida, A, Cicin, I, Harputluoglu, H, Widau, RC, Liepa, AM, Walgren, RA, Hamid, O, Zimmermann, AH, Bell-McGuinn, KM, Powles, T, Wong, S-LS, Tan, TH, Hovey, EJ, Clay, TD, Ng, SSW, Rutten, A, Machiels, J-P, Dumez, H, Cheng, SY-S, Ferrario, C, Sengeloev, L, Jensen, NV, Thibault, C, Laguerre, B, Joly, F, Flechon, A, Culine, S, Becht, C, Niegisch, G, Stöckle, M, Grimm, M-O, Gakis, G, Schultze-Seemann, W, Kalofonos, H, Mavroudis, D, Papandreou, C, Karavasilis, V, Révész, J, Geczi, L, Rosenbaum, E, Leibowitz-Amit, R, Kejzman, D, Sarid, D, Scagliotti, GV, Bracarda, S, Massari, F, Osawa, T, Miyajima, N, Shinohara, N, Fukuta, F, Ohyama, C, Obara, W, Yamashita, S, Tomita, Y, Kawai, K, Fukasawa, S, Oyama, M, Yonese, J, Nagata, M, Uemura, M, Nishimura, K, Kawakita, M, Tsunemori, H, Hashine, K, Inokuchi, J, Yokomizo, A, Nagamori, S, Lee, HJ, Park, SH, Rha, SY, Kim, YJ, Lee, Y-G, Cortés, LV, Flores, CLU, Blaisse, RJB, Erdkamp, FLG, Aarts, MJB, Wojcik-Tomaszewska, J, Tomczak, P, Sikora-Kupis, B, Schenker, M, Herzal, AA, Udrea, AA, Karlov, P, Safina, SZ, Fomkin, R, Pulido, EG, Del Muro, FXG, Mignorance, JID, Gauna, DC, Rodríguez-Vida, A, Su, Y-L, Lin, C-L, Lin, C-C, Yeh, S-P, Çiçin, I, Erman, M, Urun, Y, Golovko, Y, Bondarenko, I, Sinielnikov, I, Crabb, S, Syndikus, I, Huddart, R, Sundar, S, Chowdhury, S, Sarwar, N, Flaig, T, Pan, CX, Petrylak, D, Schwarz, J, Percent, I, Cultrera, J, Hainsworth, J, Herms, B, Lawler, W, Lowe, T, Tagawa, S, Aragon-Ching, J, Vaishampayan, U
مصطلحات موضوعية: Adult, Aged, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Transitional Cell, Disease-Free Survival, Docetaxel, Double-Blind Method, Female, Humans, Internationality, Kaplan-Meier Estimate, Male, Middle Aged, Neoadjuvant Therapy, Neoplasm Invasiveness, Neoplasm Staging, Prognosis, Proportional Hazards Models, Risk Assessment, Survival Analysis, Taxoids, Treatment Outcome, Urinary Bladder Neoplasms, Ramucirumab
وصف الملف: 2266-2277; Print-Electronic; application/pdf
Relation: E-ISSN:1474-547X; http://hdl.handle.net/10026.1/10985
الاتاحة: http://hdl.handle.net/10026.1/10985
https://doi.org/10.1016/S0140-6736(17)32365-6
Full Text Finder